jueves, 3 de octubre de 2019

Performance evaluation of propensity score methods for estimating average treatment effects with multi-level treatments. - PubMed - NCBI

Performance evaluation of propensity score methods for estimating average treatment effects with multi-level treatments. - PubMed - NCBI



 2019;46(5):853-873. doi: 10.1080/02664763.2018.1523375. Epub 2018 Sep 23.

Performance evaluation of propensity score methods for estimating average treatment effects with multi-level treatments.

Nian H1Yu C1Ding J2,3,4Wu H5Dupont WD1Brunwasser S3,4Gebretsadik T1Hartert TV3,4Wu P1,3,4.

Author information


1
Department of Biostatistics, Vanderbilt University, Nashville, TN, USA.
2
School of Mathematics and Statistics, Guangxi Normal University, Guilin, Guangxi, People's Republic of China.
3
Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University, Nashville, TN, USA.
4
Center for Asthma and Environmental Sciences Research, School of Medicine, Vanderbilt University, Nashville, TN, USA.
5
Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA.

Abstract

The propensity score (PS) method is widely used to estimate the average treatment effect (TE) in observational studies. However, it is generally confined to the binary treatment assignment. In an extension to the settings of a multi-level treatment, Imbens proposed a generalized propensity score which is the conditional probability of receiving a particular level of the treatment given pre-treatment variables. The average TE can then be estimated by conditioning solely on the generalized PS under the assumption of weak unconfounded-ness. In the present work, we adopted this approach and conducted extensive simulations to evaluate the performance of several methods using the generalized PS, including subclassification, matching, inverse probability of treatment weighting (IPTW), and covariate adjustment. Compared with other methods, IPTW had the preferred overall performance. We then applied these methods to a retrospective cohort study of 228,876 pregnant women. The impact of the exposure to different types of the antidepressant medications (no exposure, selective serotonin reuptake inhibitor (SSRI) only, non-SSRI only, and both) during pregnancy on several important infant outcomes (birth weight, gestation age, preterm labor, and respiratory distress) were assessed.

KEYWORDS:

Generalized propensity score; maternal antidepressant; multi-level treatment

PMID:
 
31274945
 
PMCID:
 
PMC6609155
 [Available on 2020-01-01]
 
DOI:
 
10.1080/02664763.2018.1523375

No hay comentarios: